Perrigo (PRGO) Scheduled to Post Quarterly Earnings on Tuesday

Perrigo (NYSE:PRGO) is scheduled to be issuing its quarterly earnings data before the market opens on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.24 per share for the quarter. Perrigo has set its FY 2024 guidance at 2.500-2.650 EPS and its FY24 guidance at $2.50 to $2.65 EPS.Persons that wish to listen to the company’s earnings conference call can do so using this link.

Perrigo (NYSE:PRGO) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.83 by $0.03. The company had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.17 billion. Perrigo had a positive return on equity of 7.34% and a negative net margin of 0.27%. The firm’s quarterly revenue was up .1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.75 earnings per share. On average, analysts expect Perrigo to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Perrigo Stock Performance

Shares of NYSE:PRGO opened at $32.79 on Monday. The business’s 50-day simple moving average is $30.60 and its 200 day simple moving average is $30.89. The company has a market cap of $4.44 billion, a P/E ratio of -327.90 and a beta of 0.63. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.07 and a current ratio of 1.79. Perrigo has a one year low of $25.77 and a one year high of $40.28.

Perrigo Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 18th. Stockholders of record on Friday, May 31st will be paid a dividend of $0.276 per share. The ex-dividend date of this dividend is Friday, May 31st. This represents a $1.10 dividend on an annualized basis and a dividend yield of 3.37%. Perrigo’s dividend payout ratio is currently -1,100.00%.

Insider Buying and Selling at Perrigo

In other Perrigo news, EVP Alison Ives purchased 2,490 shares of Perrigo stock in a transaction dated Tuesday, March 5th. The shares were bought at an average cost of $27.26 per share, for a total transaction of $67,877.40. Following the transaction, the executive vice president now owns 16,122 shares in the company, valued at approximately $439,485.72. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Perrigo news, CEO Patrick Lockwood-Taylor purchased 9,500 shares of the business’s stock in a transaction dated Thursday, February 29th. The shares were bought at an average price of $26.54 per share, with a total value of $252,130.00. Following the completion of the acquisition, the chief executive officer now owns 20,500 shares in the company, valued at approximately $544,070. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Alison Ives acquired 2,490 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The stock was acquired at an average cost of $27.26 per share, with a total value of $67,877.40. Following the completion of the acquisition, the executive vice president now directly owns 16,122 shares in the company, valued at $439,485.72. The disclosure for this purchase can be found here. Insiders acquired a total of 17,990 shares of company stock worth $475,227 over the last 90 days. Insiders own 0.40% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on PRGO. Canaccord Genuity Group reaffirmed a “buy” rating and set a $42.00 target price on shares of Perrigo in a research report on Friday, April 12th. StockNews.com raised shares of Perrigo from a “hold” rating to a “buy” rating in a research report on Wednesday, April 3rd. Piper Sandler upped their target price on shares of Perrigo from $35.00 to $39.00 and gave the company an “overweight” rating in a research note on Monday, April 8th. Finally, JPMorgan Chase & Co. decreased their price target on Perrigo from $48.00 to $41.00 and set an “overweight” rating for the company in a research note on Wednesday, February 28th.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.